Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US0153511094
Ticker ALXN
Company ALEXION PHARMACEUTICALS
Currency $
Price
Aware Investor Index (AII) 0.0005
Recommendation STRONG SELL
P/E 93.45
ROE 3.05 %
Capitalization 26,136,290,000 $
Dividend Yield 0.00 %
P/S 6.33
AII Position 685
P/E Position 677
ROE Position 686
Capitalization Position 321
Dividend Yield Position 594
Sales 4,131,200,000 $
10-Year Average Earnings 279,682,500 $
Shares Outstanding 224,500,000
Equity 9,165,300,000 $
Dividend per Share 0 $
Industry Pharmaceutical
Country United States
ALEXION PHARMACEUTICALS Investor Relations Web Site http://ir.alexion.com/







Sales:

YEAR MONTH AMOUNT
2018 12 4,131,200,000.00 $
2017 12 3,551,100,000.00 $
2016 12 3,084,100,000.00 $
2015 12 2,604,047,000.00 $
2014 12 2,233,733,000.00 $
2013 12 1,551,346,000.00 $
2012 12 1,134,114,000.00 $
2011 12 783,431,000.00 $
2010 12 540,957,000.00 $
2009 12 386,800,000.00 $

Earnings:

YEAR MONTH AMOUNT
2018 12 77,600,000.00 $
2017 12 443,300,000.00 $
2016 12 399,400,000.00 $
2015 12 144,385,000.00 $
2014 12 656,912,000.00 $
2013 12 252,895,000.00 $
2012 12 254,822,000.00 $
2011 12 175,315,000.00 $
2010 12 97,030,000.00 $
2009 12 295,166,000.00 $

Equity:

YEAR MONTH AMOUNT
2018 12 9,165,300,000.00 $
2017 12 8,893,100,000.00 $
2016 12 8,693,800,000.00 $
2015 12 8,258,616,000.00 $
2014 12 3,302,018,000.00 $
2013 12 2,382,079,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2018 12 224,500,000
2017 12 225,400,000
2016 12 226,300,000
2015 12 215,933,000
2014 12 201,623,000
2013 12 199,712,000

 












Bloomberg News for ALEXION PHARMACEUTICALS:



Google News for ALEXION PHARMACEUTICALS:

Stocks Beat - 8 hours ago
Reviewing Foamix Pharmaceuticals Ltd. (FOMX)'s and Alexion ...
Both Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) and Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) are Biotechnology companies, ...
Stocks Beat - 1 day ago
Cam Group Holding A Lowered Its Alexion Pharmaceuticals (ALXN ...
Cam Group Holding A decreased its stake in Alexion Pharmaceuticals Inc (ALXN) by 8.28% based on its latest 2019Q1 regulatory filing with the ...
The News Heater
Contrasting of Alexion Pharmaceuticals Inc. (ALXN) and Celldex ...
We will be comparing the differences between Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) and Celldex Therapeutics Inc. (NASDAQ:CLDX) ...
The Dwinnex
Do Analysts See Any Upside to Alexion Pharmaceuticals, Inc ...
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) currently has an Average Broker Rating of 1.61. This number is based on the 14 sell-side firms ...
Finch News
Alexion Pharmaceuticals, Inc. ($ALXN)'s EBITDA/Enterprise Value of ...
The VC1 of Alexion Pharmaceuticals, Inc. (ALXN) is 48. A company with a value of 0 is thought to be an undervalued company, while a ...
Stocks Beat - 1 day ago
Cyclacel Pharmaceuticals Inc. (CYCC) and Alexion Pharmaceuticals ...
As Biotechnology businesses, Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC) and Alexion Pharmaceuticals Inc. (NASDAQ:ALXN), are ...
Stock Muse - 6 hours ago
Stock Under Review:: Alexion Pharmaceuticals, Inc., (NASDAQ: ALXN)
On Thursday the USA Stock Exchange company, Alexion Pharmaceuticals, Inc., (NASDAQ: ALXN), the Trending-Graph. Each buying and ...
Yahoo Finance
Rivulet Capital Boosted Its Dollar Tree (DLTR) Holding by $2.07 ...
Westpac Banking Corp increased its stake in Alexion Pharmaceuticals Inc (ALXN) by 4.4% based on its latest 2019Q1 regulatory filing with the ...
Stocks Beat
Alexion Pharmaceuticals Inc. (ALXN)'s Financial Results Comparing ...
Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) and Protagonist Therapeutics Inc. (NASDAQ:PTGX), are influenced by contrast since they are ...
Rockland Register
Sio Capital Management Has Upped Its Alexion Pharmaceuticals ...
Sio Capital Management Llc increased its stake in Alexion Pharmaceuticals Inc (ALXN) by 108.36% based on its latest 2019Q1 regulatory filing ...


Back